OPS
OPNT

Orion Portfolio Solutions’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Orion Portfolio Solutions’s Portfolio OPNT Stock Details OPNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-450
Closed -$4K – 2225
2020
Q2 		$4K Hold
450
– – ﹤0.01% 1599
2020
Q1 		$4K Buy
+450
New +$5.39K ﹤0.01% 1410

Other funds holding OPNT

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Orion Portfolio Solutions's OPNT Position: Q3 2020 in Review

Orion Portfolio Solutions sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q3 2020, closing a stake of 450 shares — an estimated $4K sold.

Orion Portfolio Solutions first reported a position in OPNT in Q1 2020 and held it in 2 quarters. The position peaked at $4K in Q2 2020. 28 funds tracked by Wall St. Rank hold OPNT as of Q3 2020.

  • Orion Portfolio Solutions reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Orion Portfolio Solutions sold 450 Opiant Pharmaceuticals, Inc. Common Stock shares in Q3 2020, an estimated $4K.
  • Orion Portfolio Solutions first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 2 quarters.
  • Orion Portfolio Solutions's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $4K in Q2 2020.
  • 28 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q3 2020.

Based on Orion Portfolio Solutions's 13F filing for Q3 2020, filed 13 Nov 2020.